2359
Pending Latest rating：Buy
Entry zone
189.1 – 196.2
Near market · as of 2026-10-16
Stop
182.6
initial distance -6.9%
Full size
10.0%
in tranches 40% / 30% / 30%
Support / resistance
189.1 / 223.5
ATR(14) 9.08
CloseEntry zoneStop
Triggers
- ArmedFirst tranche: price enters the entry zone4.0%@ 196.2
- ArmedAdd 1: pullback holds support (confirmed at close, executed next open)3.0%@ 191.3
- ArmedAdd 2: breakout above resistance on volume, held 2 days3.0%@ 223.5
- ArmedStop: sell everything below this price@ 182.6
Timeline
- Entered pool@ 196.2
Rating historyChinese only
- Buy现价在 189.05–196.20 入场区间上沿；AI 制药越繁荣，越需要"湿实验"产能这一物理瓶颈；止损 182.57
- Buy略高于候补区间 189.05–196.20；fPE 18.8 配 CRDMO 全球份额，财报前分批，止损 182.57
- Buy长期趋势完好，放量震荡是财报前换手；现价在候补入场区 189.05–196.20 上沿，止损 182.57
- Buy1.17 的 recommendationMean 是全港股最强共识，200 日均线上方 33.5% 的趋势完好，10-26 业绩是近端催化；回踩 50 日均线 201 以内分批，破 185（当日最低）止损
Earlier rounds
| In | Out | Entry | P&L | R | Exit reason |
|---|---|---|---|---|---|
| 2026-10-08 | 2026-10-09 | 209.4 | -5.3% | -1.04 | Stop loss |
| 2026-09-14 | 2026-09-15 | 186 | +4.3% | 0.73 | Trailing stop |
Paper portfolio executed mechanically from published rules. Not real trades, not investment advice.